The new data show that a single injection of AB-729 @60mg worked as well as a single injection of AB-729 @180mg in generating a ~1.0-log reduction in HBsAg relative to baseline at 12 weeks.
That 1 log reduction is misleading, *forced* by single subject! Still, how to explain 180 mg dose failure IF 60 mg is so-so?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.